Postmenopausal hyperthecosis: functional dysregulation of androgenesis in climacteric ovary.
BACKGROUND
Hyperandrogenism of ovarian origin is rare in postmenopausal women. However, there is evidence that the ovaries of postmenopausal women are active endocrine glands, secreting mainly androgens.


METHODS
A postmenopausal woman sought treatment for progressive hirsutism. Endocrine evaluation revealed androgen excess. Transvaginal ultrasound revealed enlarged ovaries. Hysterectomy and bilateral oophorectomy were recommended. However, surgery had to be withheld for 6 months while the patient recovered from an acute myocardial infarction. In the interim, the patient's hyperandrogenemia was successfully treated with monthly injections of the gonadotropin-releasing hormone agonist (GnRH), leuprolide acetate.


CONCLUSIONS
This report illustrates the potential for postmenopausal ovaries to become active androgen-secreting endocrine organs. It also demonstrates the efficacy of pharmacologic intervention for postmenopausal ovarian hyperthecosis when the patient is a poor surgical candidate.
Krug
Esther
E
Division of Endocrinology, Department of Medicine, The University of Pittsburgh School of Medicine and Magee-Womens Hospital, Pittsburgh, Pennsylvania, USA.
Berga
Sarah L
SL
D000465:Algorithms; D005260:Female; D006801:Humans; D017588:Hyperandrogenism / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D016729:Leuprolide / Q000627:therapeutic use; D008875:Middle Aged; D010053:Ovary / Q000503:physiopathology*; D017698:Postmenopause
D016729:Leuprolide